We also determined the LKB1 and TP53 status, following previously validated IHC analysis 13, 20, 22; whereas most tumours showed varying but positive nuclear TP53 protein accumulation, suggesting TP53 pathway mutation, LKB1 expression varied across NSCLC pathologies. This evidence concerns the gene STK11 and non-small cell lung carcinoma.